Paper32166314
MGMT promoter methylation level in newly diagnosed low-grade glioma is a predictor of hypermutation at recurrence.
Mathur R and 13 others. Neuro Oncol, 2020. Cited by 72 papers, by iCite.
Cite this record
ConductScience Library. MGMT promoter methylation level in newly diagnosed low-grade glioma is a predictor of hypermutation at recurrence. Papers, record 32166314. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32166314
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Brain Neoplasms | Major topic |
| DNA Modification Methylases | Major topic |
| DNA Repair Enzymes | Major topic |
| Glioma | Major topic |
| Tumor Suppressor Proteins | Major topic |
| Antineoplastic Agents, Alkylating | |
| DNA Methylation | |
| Humans | |
| Neoplasm Recurrence, Local | |
| Temozolomide |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| T32 CA151022 | NCI NIH HHS | United States | T32CA151022 | PubMed and NIH | NIH RePORTER |
| R01 CA169316 | NCI NIH HHS | United States | R01CA169316 | PubMed and NIH | NIH RePORTER |
| P50 CA097257 | NCI NIH HHS | United States | P50CA097257 | PubMed and NIH | NIH RePORTER |
| T32 GM008568 | NIGMS NIH HHS | United States | T32GM008568 | PubMed and NIH | NIH RePORTER |
| F32 CA239472 | NCI NIH HHS | United States | F32CA239472 | PubMed and NIH | NIH RePORTER |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 32927482 | MGMT promoter methylation and hypermutant recurrence in IDH mutant lower-grade glioma. | https://conductscience.org/library/papers/32927482 |
Source PubMed
References49
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10029064 | Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. | Cancer Res | 1999 | https://conductscience.org/library/papers/10029064 | PubMed |
| 2 | 24227677 | featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. | Bioinformatics | 2014 | https://conductscience.org/library/papers/24227677 | PubMed |
| 3 | 15758010 | MGMT gene silencing and benefit from temozolomide in glioblastoma. | N Engl J Med | 2005 | https://conductscience.org/library/papers/15758010 | PubMed |
| 4 | 27571885 | Chemotherapy for adult low-grade gliomas: clinical outcomes by molecular subtype in a phase II study of adjuvant temozolomide. | Neuro Oncol | 2017 | https://conductscience.org/library/papers/27571885 | PubMed |
| 5 | 12815001 | Formation of DNA adducts and induction of lacI mutations in Big Blue Rat-2 cells treated with temozolomide: implications for the treatment of low-grade adult and pediatric brain tumors. | Cancer Epidemiol Biomarkers Prev | 2003 | https://conductscience.org/library/papers/12815001 | PubMed |
| 6 | 26927331 | Sensitivity Analysis of the MGMT-STP27 Model and Impact of Genetic and Epigenetic Context to Predict the MGMT Methylation Status in Gliomas and Other Tumors. | J Mol Diagn | 2016 | https://conductscience.org/library/papers/26927331 | PubMed |
| 7 | 21148162 | The correlation between promoter methylation status and the expression level of O6-methylguanine-DNA methyltransferase in recurrent glioma. | Jpn J Clin Oncol | 2011 | https://conductscience.org/library/papers/21148162 | PubMed |
| 8 | 27157931 | The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. | Acta Neuropathol | 2016 | https://conductscience.org/library/papers/27157931 | PubMed |
| 9 | 22810491 | MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status. | Acta Neuropathol | 2012 | https://conductscience.org/library/papers/22810491 | PubMed |
| 10 | 25724300 | Evolution of DNA repair defects during malignant progression of low-grade gliomas after temozolomide treatment. | Acta Neuropathol | 2015 | https://conductscience.org/library/papers/25724300 | PubMed |
| 11 | 16632515 | Adjusting batch effects in microarray expression data using empirical Bayes methods. | Biostatistics | 2007 | https://conductscience.org/library/papers/16632515 | PubMed |
| 12 | 20372840 | Changes of the O6-methylguanine-DNA methyltransferase promoter methylation and MGMT protein expression after adjuvant treatment in glioblastoma. | Oncol Rep | 2010 | https://conductscience.org/library/papers/20372840 | PubMed |
| 13 | 20375111 | partDSA: deletion/substitution/addition algorithm for partitioning the covariate space in prediction. | Bioinformatics | 2010 | https://conductscience.org/library/papers/20375111 | PubMed |
| 14 | 27001570 | Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency. | J Clin Oncol | 2016 | https://conductscience.org/library/papers/27001570 | PubMed |
| 15 | 19224763 | Identification of regions correlating MGMT promoter methylation and gene expression in glioblastomas. | Neuro Oncol | 2009 | https://conductscience.org/library/papers/19224763 | PubMed |
| 16 | 27270107 | Clonal evolution of glioblastoma under therapy. | Nat Genet | 2016 | https://conductscience.org/library/papers/27270107 | PubMed |
| 17 | 31263031 | Genomic Correlates of Disease Progression and Treatment Response in Prospectively Characterized Gliomas. | Clin Cancer Res | 2019 | https://conductscience.org/library/papers/31263031 | PubMed |
| 18 | 25516281 | Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. | Genome Biol | 2014 | https://conductscience.org/library/papers/25516281 | PubMed |
| 19 | 27686946 | Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study. | Lancet Oncol | 2016 | https://conductscience.org/library/papers/27686946 | PubMed |
| 20 | 27943684 | Treatment Strategies for Low-Grade Glioma in Adults. | J Oncol Pract | 2016 | https://conductscience.org/library/papers/27943684 | PubMed |
Cited by59
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 72 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42368494 | Ensemble Machine Learning Approaches Predict Survival in Lower-Grade Glioma Based on Glycosphingolipid Gene Expression and Metabolic Modeling. | Comput Struct Biotechnol J | 2026 | https://conductscience.org/library/papers/42368494 | PubMed |
| 42313202 | MGMT promoter methylation across glioma subtypes: biological relevance, treatment response, and survival outcomes. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42313202 | PubMed |
| 42192542 | Integrin-binding sialoprotein as an extracellular matrix-associated independent prognostic biomarker in glioma. | BMC Cancer | 2026 | https://conductscience.org/library/papers/42192542 | PubMed |
| 42147219 | Case Report: Identification of rare H3-3A p.G35W variant in a case of adolescent tectal plate low-grade glioma. | Front Oncol | 2026 | https://conductscience.org/library/papers/42147219 | PubMed |
| 41838210 | GPR40 Attenuates Glioma TMZ-Resistance Through Ferroptosis Inhibition. | Neurochem Res | 2026 | https://conductscience.org/library/papers/41838210 | PubMed |
| 41462160 | Prognostic value of LPAR1 expression and methylation in low-grade gliomas: a meta-analysis of TCGA and CGGA datasets and functional validation. | BMC Cancer | 2025 | https://conductscience.org/library/papers/41462160 | PubMed |
| 40949165 | IDH mutant high-grade gliomas. | Front Mol Neurosci | 2025 | https://conductscience.org/library/papers/40949165 | PubMed |
| 40739045 | Predictive efficacy and role of 2HG in MGMT promoter methylation in gliomas: a retrospective study based on MRS and mediator variable analysis. | Br J Cancer | 2025 | https://conductscience.org/library/papers/40739045 | PubMed |
| 40041202 | Clinical value of the MGMT promoter methylation score in IDHmt low-grade glioma for predicting benefit from temozolomide treatment. | Neurooncol Adv | 2025 | https://conductscience.org/library/papers/40041202 | PubMed |
| 39990688 | Research trends in glioma chemoradiotherapy resistance: a bibliometric analysis (2003-2023). | Front Oncol | 2025 | https://conductscience.org/library/papers/39990688 | PubMed |
| 39745907 | Functional germline variants in DNA damage repair pathways are associated with altered survival in adults with glioma treated with temozolomide. | Neuro Oncol | 2025 | https://conductscience.org/library/papers/39745907 | PubMed |
| 39560080 | Longitudinal multimodal profiling of IDH-wildtype glioblastoma reveals the molecular evolution and cellular phenotypes underlying prognostically different treatment responses. | Neuro Oncol | 2025 | https://conductscience.org/library/papers/39560080 | PubMed |
| 39555702 | DSN1 may predict poor prognosis of lower-grade glioma patients and be a potential target for immunotherapy. | Cancer Biol Ther | 2024 | https://conductscience.org/library/papers/39555702 | PubMed |
| 39031395 | Analysis of glutathione Stransferase mu class 5 gene methylation as a prognostic indicator in low-grade gliomas. | Technol Health Care | 2024 | https://conductscience.org/library/papers/39031395 | PubMed |
| 38948079 | STAT3 drives the malignant progression of low-grade gliomas through modulating the expression of STAT1, FOXO1, and MYC. | Front Mol Biosci | 2024 | https://conductscience.org/library/papers/38948079 | PubMed |
| 38912846 | The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors? | Neuro Oncol | 2024 | https://conductscience.org/library/papers/38912846 | PubMed |
| 38690285 | Case report: Temozolomide induced hypermutation indicates an unfavorable response to immunotherapy in patient with gliomas. | Front Immunol | 2024 | https://conductscience.org/library/papers/38690285 | PubMed |
| 38438348 | Trans-lesion synthesis and mismatch repair pathway crosstalk defines chemoresistance and hypermutation mechanisms in glioblastoma. | Nat Commun | 2024 | https://conductscience.org/library/papers/38438348 | PubMed |
| 38117484 | The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment Regimen. | Cancer Res | 2024 | https://conductscience.org/library/papers/38117484 | PubMed |
| 37905107 | Trans-Lesion Synthesis and Mismatch Repair Pathway Crosstalk Defines Chemoresistance and Hypermutation Mechanisms in Glioblastoma. | bioRxiv | 2023 | https://conductscience.org/library/papers/37905107 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| IDH1 | 3417 | PubTator's text mining | https://conductscience.org/library/genes/3417 | NCBI Gene |
| MGMT | 4255 | PubTator's text mining | https://conductscience.org/library/genes/4255 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32166314
GET https://conductscience.org/api/papers/v1/32166314/references?page=2